Zhu Ming, Liu Xiao-rong, Huang Yan-qin, Yuan Ying, Li Jin-tian, Zhang Xiao-mei, Zhang Yuan-ying, Wang Ya-ping
Department of Molecular Biology, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, P. R. China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Dec;22(6):603-6.
To investigate the frequency of large fragment aberrations of MSH2 and MLH1 genes from Chinese colorectal cancer (CRC) patients with family history.
Sixteen exons of MSH2, nineteen exons of MLH1 and seven DNA sequences from the other genes of the samples were screened and checked by multiplex ligation dependent probe amplification (MLPA). First, the methodology was confirmed by testing the positive and negative control samples. Then, 32 CRC or hereditary nonpolyposis colorectal cancer (HNPCC) patients with family history and 20 cases of sporadic CRC were applied to investigate for the large fragment aberrations of MSH2 and MLH1 genes.
The genomic DNA fragment deletions of all positive controls were identified and verified by MLPA. Three cases of 32 familial (hereditary) CRC/HNPCC were detected and identified to be the germline heterozygous deletions of MSH2 gene, of which exons 1-7 were deleted from patient No.3, exon 11 from No.25 and exons 2-6 from No.11. However, no genomic DNA fragment aberration of either MSH2 or MLH1 gene was uncovered from 20 sporadic CRC.
Large DNA fragment aberrations of MSH2 gene was a frequent cause of Chinese HNPCC and CRC patients with family history, and the identification of those aberrations should be included in the regular genetic analysis for CRC/HNPCC patients.
研究中国有家族史的结直肠癌(CRC)患者中MSH2和MLH1基因大片段畸变的频率。
采用多重连接依赖探针扩增技术(MLPA)对样本中MSH2的16个外显子、MLH1的19个外显子以及其他基因的7个DNA序列进行筛选和检测。首先,通过检测阳性和阴性对照样本对方法进行确认。然后,对32例有家族史的CRC或遗传性非息肉病性结直肠癌(HNPCC)患者以及20例散发性CRC患者进行研究,以检测MSH2和MLH1基因的大片段畸变。
通过MLPA鉴定并验证了所有阳性对照的基因组DNA片段缺失。在32例家族性(遗传性)CRC/HNPCC患者中,检测到3例并鉴定为MSH2基因的种系杂合缺失,其中3号患者的外显子1-7缺失,25号患者的外显子11缺失,11号患者的外显子2-6缺失。然而,在20例散发性CRC中未发现MSH2或MLH1基因的基因组DNA片段畸变。
MSH2基因的大片段DNA畸变是中国有家族史的HNPCC和CRC患者的常见病因,对这些畸变的鉴定应纳入CRC/HNPCC患者的常规基因分析中。